top of page
Impact
idea + capital + scale
Funding at scale is what transforms promising ideas into global game-changers.
When investment reaches a critical mass, it drives widespread adoption, fuels rapid expansion, and enables startups to create lasting economic and social impact.
Scaled funding empowers companies to hire and develop top talent, enter new markets, and build infrastructure that sustains long-term growth.
This ripple effect doesn’t just benefit individual businesses—it accelerates technological progress, ultimately shaping the future at a much larger scale.
'Our belief system is rooted in ecosystem thinking. Those who will thrive in the next decade are the ones who embrace their role in the ecosystem and actively collaborate to advance it.'
Ariane Cruz Gomes
Baseimmune, United Kingdom
£9M in February
_edited.jpg)
The vast majority of ecosystem players believe that access to funding is essential for driving innovation
Compared to 12 months ago, is it easier or harder to raise external capital in Europe?
Significantly easier
Easier
No change
Harder
Significantly harder
Add a Title
91%
Add a Title
3%
Add a Title
6%
Add a Title
6%
Add a Title
6%
Source: Female Innovation Index Survey 2026
'We are no longer only a robotics company. We’re now measured against leading AI and full-stack companies that are worth billions—like SpaceX or Apple—which mean an even higher level of expectation and ambition.'
Oana Jinga, DEXORY
United Kingdom
€143M in October
The Fifty
Innovators List
Funding at scale is what transforms promising ideas into global game-changers.
When investment reaches a critical mass, it drives widespread adoption, fuels rapid expansion, and enables startups to create lasting economic and social impact.
Scaled funding empowers companies to hire and develop top talent, enter new markets, and build infrastructure that sustains long-term growth.
This ripple effect doesn’t just benefit individual businesses—it accelerates technological progress, ultimately shaping the future at a much larger scale.
50 female-founded companies in Europe that raised the biggest funding rounds in 2025
Company | Round size (€M) | Round | Sector | Country |
|---|---|---|---|---|
WorldRemit | 243 | GROWTH VC | fintech | United Kingdom |
The Exploration Company | 150 | SERIES B | space | Germany |
Newcleo | 135 | SERIES A | energy | France |
Pigment | 132 | SERIES D | fintech, enterprise software | France |
ŌURA | 114, 68 | SERIES D | health, wellness beauty | Finland |
Oda | 110 | LATE VC | food | Norway |
Akur8 | 109 | SERIES C | fintech, enterprise software | France |
Medical Microinstruments | 100 | SERIES C | health, robotics | Italy |
Abound | 96 | SERIES B | fintech | United Kingdom |
Razor | 91 | GROWTH VC | marketing | Germany |
Syre | 91 | SERIES A | fashion | Sweden |
Agomab Therapeutics | 81 | SERIES D | health | Belgium |
iOnctura | 80 | SERIES B | health | Switzerland |
Antag Therapeutics | 80 | SERIES A | health | Denmark |
Resolution Therapeutics | 76 | SERIES B | health, music | United Kingdom |
Nouscom | 76 | SERIES C | health | Switzerland |
Impress | 70 | LATE VC | health, wellness beauty | Spain |
Cradle | 66 | SERIES B | health, chemicals | Netherlands |
Prewave | 63 | SERIES B | transportation, enterprise software | Austria |
UrbanChain | 60 | SERIES B | energy | United Kingdom |
Colendi | 59 | SERIES B | fintech | United Kingdom |
cylib | 55 | SERIES A | energy | Germany |
Vico Therapeutics | 54 | SERIES B | health | Netherlands |
Infinite Roots | 53 | SERIES B | food | Germany |
Dexory | 51 | SERIES B | robotics, enterprise software | United Kingdom |
Sana Labs | 50 | SERIES B | education, enterprise software | Sweden |
Natural Cycles | 50 | SERIES C | health, wellness beauty | Sweden |
Carwow | 47 | LATE VC | transportation | United Kingdom |
Inbrain Neuroelectronics | 46 | SERIES B | health | Spain |
GrowUP Farms | 46 | LATE VC | food | United Kingdom |
Zelt | 45 | SERIES A | jobs recruitment, enterprise software | United Kingdom |
LoQus23 Therapeutics | 42 | SERIES A | health | United Kingdom |
Cilcare | 40 | SERIES A | health | France |
Again | 39 | SERIES A | chemicals | Denmark |
ENYO Pharma | 39 | SERIES C | health | France |
Nuritas | 38 | SERIES C | health, food | Ireland |
Aqemia | 30, 36 | EARLY VC | health | France |
Abolis Biotechnologies | 35 | LATE VC | chemicals | France |
Doconomy | 33 | EARLY VC | fintech, enterprise software | Sweden |
Bioptimus | 32 | SEED | health | France |
Asgard Therapeutics | 30 | SERIES A | health | Sweden |
Onera | 30 | SERIES C | health | Netherlands |
Tebrio | 30 | EARLY VC | food | Spain |
Datamaran | 30 | SERIES C | enterprise software | United Kingdom |
Easol | 27 | SERIES A | travel, marketing | United Kingdom |
Planet A Foods | 27 | SERIES B | food | Germany |
Onego Bio | 27 | SERIES A | health, food | Finland |
FYLD | 26 | LATE VC | security, enterprise software | United Kingdom |
Cutiss | 25 | SERIES C | health | Switzerland |
Agrilife Studio | 25 | EARLY VC | food, jobs recruitment | France |
.png)
Data source: Dealroom
Company profiles
145M
The biggest round (€) raised in 2025
Top sectors
8%
Energy
40%
Health
12%
Food
4%
Transport
14%
Fintech
7.62Y
Average company age
Top HQ locations
26%
United Kingdom
16%
France
10%
Sweden
10%
Germany
8%
Spain
Founder profiles
81%
founders on the Fifty Innovators List have
a scientific background
Female-only vs gender-mixed teams
female-only
Add a Title
9%
gender-mixed
Add a Title
91%
Solo founder vs founding team
solo
Add a Title
2%
team
Add a Title
98%
Founder age group
Founder education
20-30 years old
30-40 years old
40-50 years old
50-60 years old
60 -70 years old
Add a Title
0%
Add a Title
31%
Add a Title
41%
Add a Title
22%
Add a Title
2%
Masters degree
PhD
Bachelors degree
MBA
Lower than Bachelors
Add a Title
38%
Add a Title
32%
Add a Title
22%
Add a Title
5%
Add a Title
0%
Data source: Dealroom
'Our belief system is rooted in ecosystem thinking. Those who will thrive in the next decade are the ones who embrace their role in the ecosystem and actively collaborate to advance it.'
Laura Hutton, Quantexa
United Kingdom
€159M in March
.png)
The vast majority of ecosystem players believe that access to funding is essential for driving innovation
Compared to 12 months ago, is it easier or harder to attract technical talent in Europe?
Significantly easier
Easier
No change
Harder
Significantly harder
Add a Title
91%
Add a Title
3%
Add a Title
6%
Add a Title
6%
Add a Title
6%
Source: Female Innovation Index Survey 2026
'Our innovations aim to solve previously unsolvable problems and enhance existing vaccines to make them more effective and easier to deploy—these two goals are central to our mission. We are proud to contribute to these advancements in public health.'
Ariane Cruz Gomes
Baseimmune, United Kingdom
Raised £9m in February
Coming up
Deeptech
Deep dive
Who are the founders solving some of the hardest problems with tech? What are the key areas of innovation in deeptech?
Exits
Exits
Exits
bottom of page